<code id='5A2F16D089'></code><style id='5A2F16D089'></style>
    • <acronym id='5A2F16D089'></acronym>
      <center id='5A2F16D089'><center id='5A2F16D089'><tfoot id='5A2F16D089'></tfoot></center><abbr id='5A2F16D089'><dir id='5A2F16D089'><tfoot id='5A2F16D089'></tfoot><noframes id='5A2F16D089'>

    • <optgroup id='5A2F16D089'><strike id='5A2F16D089'><sup id='5A2F16D089'></sup></strike><code id='5A2F16D089'></code></optgroup>
        1. <b id='5A2F16D089'><label id='5A2F16D089'><select id='5A2F16D089'><dt id='5A2F16D089'><span id='5A2F16D089'></span></dt></select></label></b><u id='5A2F16D089'></u>
          <i id='5A2F16D089'><strike id='5A2F16D089'><tt id='5A2F16D089'><pre id='5A2F16D089'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:271
          Richard Burr
          North Carolina Senator Richard Burr received strong support from the biotech sector. Gerry Broome/AP

          WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

          North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

          advertisement

          Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Charles Manson follower Leslie Van Houten released from prison after 53 years
          Charles Manson follower Leslie Van Houten released from prison after 53 years

          1:54LeslieVanHoutenattendsherparolehearingattheCaliforniaInstitutionforWomenSept.6,2017inCorona,Cali

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

          MollyFerguson/STATThoughtsaboutCytokineticsafterWednesdaynight’sfinancingannouncement:1.Managementis